Abstract

ObjectivesHigh-risk locally advanced cervical cancer has a poor prognosis. External beam radiotherapy (EBRT) with concurrent chemotherapy followed by brachytherapy is the standard of care. The immunostimulatory activity of pembrolizumab may...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call